Daniel Grossman, MD, is ANSIRH's Director. He focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa, as well as evaluating the impact of integrating reproductive health and HIV services. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. As a faculty member in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, Dr. Grossman performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dr. Grossman received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.
November 9, 2022
Grindlay K, Key K, Bradford R, Amato C, Blanchard K, Grossman D. Pilot label comprehension study for an over-the-counter combined oral contraceptive pill in the United States. Perspectives on Sexual and Reproductive Health. November 2022; DOI: 10.1363/psrh.12214.
November 9, 2022
Grindlay K, Key K, Zuniga C, Wollum A, Blanchard K, Grossman D. Interest in Continued Use After Participation in a Study of Over-the-Counter Progestin-Only Pills in the United States. Women's Health Reports. November 2022; DOI: 10.1089/whr.2022.0056.
November 1, 2022
Grossman D, Verma N. Self-managed Abortion in the US. JAMA. November 2022; DOI: 10.1001/jama.2022.19057.
October 30, 2022
Ruggiero SP, Seymour JW, Thompson TA, Kohn J, Snow JL, Grossman D, Fix L. Patient and provider experiences using a site-to-site telehealth model for medication abortion. MHealth. October 2022; DOI: 10.21037/mhealth-22-12.